Fresenius Medical Expects Smaller Annual Income Decline Amid Easing Cost Inflation, Labor Shortages
Portfolio Pulse from Vandana Singh
Fresenius Medical Care AG (NYSE:FMS) reported a 41% Y/Y increase in Q2 adjusted operating income to €401 million and a 51% jump in adjusted net income to €175 million. The company's revenue increased by 1% to €4.83 billion. Fresenius is on track to achieve sustainable savings of €250-300 million by year-end 2023 and €650 million by year-end 2025. The company expects 2023 operating income to remain flat or slip by up to a low-single-digit percentage.
August 04, 2023 | 11:26 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Fresenius Medical's Q2 results show increased income and revenue, and the company is on track for significant savings by 2023 and 2025. However, the company's shares are down 2.01%.
Fresenius Medical's positive Q2 results and future savings plans should have a positive impact on the company's stock. However, the company's shares are currently down, which may be due to other market factors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100